Open Access

Propofol-related urine discoloration in a patient with fatal atypical intracerebral hemorrhage treated with hypothermia

  • Martin Regensburger1, 2Email author,
  • Hagen B. Huttner1,
  • Arnd Doerfler3,
  • Stefan Schwab1 and
  • Dimitre Staykov1
SpringerPlus20143:551

https://doi.org/10.1186/2193-1801-3-551

Received: 4 March 2014

Accepted: 16 September 2014

Published: 23 September 2014

Abstract

Introduction

Mild therapeutic hypothermia is an increasingly recognised treatment option to reduce perihemorrhagic edema in severe intracerebral hemorrhage.

Case description

We report the case of a 77-year old woman with atypical intracerebral hemorrhage that was treated with mild hypothermia in addition to osmotic therapy. The patient’s urine subsequently showed a green discoloration. Urine discoloration was completely reversible upon discontinuation of propofol.

Discussion and evaluation

Propofol-related urine discoloration may have been provoked by hypothermia. Due to the benign nature of this side effect, propofol should be stopped and gastrointestinal function should be supported.

Conclusion

More studies are needed to show a causal role of hypothermia and related decreased enzymatic function.

Keywords

Hypothermia Intracerebral hemorrhage Urine discoloration Enterohepatic circulation Liver enzyme function

Case

A 77-year old woman was referred to our hospital because of acute hemiparesis of the left side. A cerebral CT scan revealed an intracerebral hemorrhage with a volume of 32 milliliter located in the right parietal cortex with concomitant right hemispheric subarachnoid blood accumulation (Figure 1A). Due to rapid worsening of the paresis and her consciousness, she was orotracheally intubated and started on imaging, Figure 1B) showed significant worsening. An external ventricular drainage was surgically put in place to prevent hydrocephalus and to control intracerebral pressure. Follow-up MRI revealed an increased size of the bleeding to 112 milliliter, large perifocal edema and a midline shift of 9 millimeter. Susceptibility weighted images revealed multiple microbleeds as a correlate of amyloid angiopathy as most probable cause of the hemorrhage (Figure 1C). There was no evidence for other causes of the initial event and for the expansion of the hematoma: Blood coagulation parameters were within normal limits, there was no history of arterial hypertension. Under the influcence of analgosedatives, blood pressure had to be supported by continuous infusion of norepinephrine and did not exceed a systolic pressure of 160 mmHg and a mean arterial blood pressure of 100 mmHg diastolic. Echocardiography was unremarkable.
Figure 1

Neuroradiological imaging results in the presented patient. A: CT-imaging on admission. B: CT-control-imaging 4 hours later. C: Susceptibility weighted MRI after 1 day. D: CT-imaging 4 days after admission and before termination of osmotic therapy and therapeutic hypothermia.

Due to the age of the patient, a decision was made against surgical hematoma evacuation and for aggressive medical treatment. To reduce edema, osmotic therapy with mannitol and hypertonic saline was started. Serum osmolality was thereby increased to 330 mosmol/kg with a sodium level of 150 mmol/l. As an additional anti-edema therapy, mild therapeutic hypothermia (35,0°C) was induced with an endovascular cooling catheter (Staykov et al. 2013).86 hours after the onset of analgosedatives and 16 hours after induction of hypothermia, we noted a green-brown discoloration of the patient’s urine (Figure 2A). Standard urine analysis was unremarkable (pH 6,5, protein neg., nitrite neg., wbc neg., ketone neg., bilirubine neg., blood neg.) and urine cultures were negative. Liver function parameters including bilirubin were normal. At the same time, obstipation in presence of enteral feeding via a nasogastral tube was treated with laxatives. Analgosedatives were switched to midazolame and sufentanil, and propofol (total amount of 14,000 mg, average infusion rate of 3.2 mg/kg/h) was discontinued. Within few hours, urine color changed back to normal (Figure 2B).

Despite maximal therapy, CT follow-up after 3 days showed significant worsening with increased edema, mesencephalic compression and subfalcine and uncal herniation (Figure 1D). Due to poor prognosis, osmotic therapy was stopped and the patient died two days later due to cerebral herniation.
Figure 2

Urine samples of the patient. A: Dark green discoloration 48 hours after the onset of propofol. B: Color changed back to normal few hours after the end of propofol administration.

Discussion

Urine discoloration due to propofol infusion has been described few times in the literature (Bodenham et al. 1987; Tan et al. 2008; Ku et al. 2011; Shioya et al. 2011; Barbara and Whalen 2012). Potential other causes include amitriptyline, indomethacin, cimetidine, metoclopramide, methocarbamol and promethazine as well as urinary tract infection or food coloring (Carpenito and Kurtz 2002; Ehrig et al. 1999; Pak 2004; Gillett and Burnett 2006; Tonseth et al. 2007; Bernante et al. 2003; Ananthanarayan and Fisher 1995). Few of these constellations reflect a harmful situation per se and neither health care staff nor relatives should be alarmed. If urine analysis is normal, the accountable drug should be identified by pausing medications that are known for this side effect.

To the best of our knowledge, this is the first report describing urine discoloration in a patient treated with osmotic therapy and mild hypothermia. Hypothermia is also known to increase the risk of tubular dysfunction, electrolyte loss and electrolyte disorders and this may be potentiated by the renal side effects of osmotic therapy (Brain Trauma Foundation 2007; Polderman et al. 2001a; Polderman et al. 2001b; Kaufman et al. 1993; Weinberg 1993). However, in our patient, creatinine and urea levels remained at baseline levels throughout her disease course and serial arterial blood analyses showed normal pH levels. Hypothermia reduces the metabolic rate by 7–9% per degree Celsius reduction of body temperature (Polderman 2004). Propofol is metabolized by hepatic and renal glucuronidation (Oda et al. 2001; McGurk et al. 1998). The mechanism of propofol-induced urine discoloration is supposed to be mediated by extrahepatic propofol glucuronidation due to decreased hepatic glucuronidation as a consequence of reduced liver enzyme function or diminished peristalsis (Shioya et al. 2011). The green color is a consequence of the excretion of the quinol derivates 4-(2,6-diisopropyl-1,4-quinol)-sulphate, 1- and 4-(2,6-diisopropyl-1,4)-glucuronide resulting from renal sulfo- and glucuroconjugation of propofol (Simons et al. 1988).

We assume that decreased liver enzyme function due to hypothermia, decreased enterohepatic circulation due to obstipation and a high-normal rate of propofol analgosedation may have provoked urine discoloration in our patient. Although urine discoloration is regarded as a benign side effect of propofol, we conclude that care should be taken in patients treated with hypothermia to maintain renal function and peristalsis. Future studies are needed to show interactions of hypothermia with the observed side effect of propofol.

Consent

Due to the fatal outcome, written informed consent for the publication of this report could not be obtained from the patient; therefore all images are anonymized.

Declarations

Authors’ Affiliations

(1)
Department of Neurology, University of Erlangen-Nuremberg
(2)
Division of Molecular Neurology, University of Erlangen-Nuremberg
(3)
Department of Neuroradiology, University of Erlangen-Nuremberg

References

  1. Ananthanarayan C, Fisher JA: Why was the urine green? Can J Anaesth 1995, 42: 87-88. 10.1007/BF03010578View ArticleGoogle Scholar
  2. Barbara DW, Whalen FX Jr: Propofol induction resulting in green urine discoloration. Anesthesiology 2012, 116: 924. 10.1097/ALN.0b013e31823a13bcView ArticleGoogle Scholar
  3. Bernante P, Francini F, Zangrandi F, et al.: Green urine after intragastric balloon placement for the treatment of morbid obesity. Obes Surg 2003, 13: 951-953. 10.1381/096089203322618858View ArticleGoogle Scholar
  4. Bodenham A, Culank LS, Park GR: Propofol infusion and green urine. Lancet 1987, 2: 740.View ArticleGoogle Scholar
  5. Brain Trauma Foundation: Guidelines for the management of severe traumatic brain injury. American Association of Neurological Surgeons, Congress of Neurological Surgeons J Neurotrauma 2007, 24(Suppl 1):S1-S106.Google Scholar
  6. Carpenito G, Kurtz I: Green urine in a critically ill patient. Am J Kidney Dis 2002, 39: E20.View ArticleGoogle Scholar
  7. Ehrig F, Waller S, Misra M, Twardowski ZJ: A case of ‘green urine’. Nephrol Dial Transplant 1999, 14: 190-192. 10.1093/ndt/14.1.190View ArticleGoogle Scholar
  8. Gillett MJ, Burnett JR: Medications and green urine. Intern Med J 2006, 36: 64-66. 10.1111/j.1445-5994.2005.00997.xView ArticleGoogle Scholar
  9. Kaufman HH, Timberlake G, Voelker J, Pait TG: Medical complications of head injury. Med Clin North Am 1993, 77: 43-60.Google Scholar
  10. Ku BD, Park KC, Yoon SS: Dark green discoloration of the urine after prolonged propofol infusion: a case report. J Clin Pharm Ther 2011, 36: 734-736. 10.1111/j.1365-2710.2010.01225.xView ArticleGoogle Scholar
  11. McGurk KA, Brierley CH, Burchell B: Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol 1998, 55: 1005-1012. 10.1016/S0006-2952(97)00534-0View ArticleGoogle Scholar
  12. Oda Y, Hamaoka N, Hiroi T, Imaoka S, Hase I, Tanaka K, Funae Y, Ishizaki T, Asada A: Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. Br J Clin Pharmacol 2001, 51: 281-285.View ArticleGoogle Scholar
  13. Pak F: Green urine: an association with metoclopramide. Nephrol Dial Transplant 2004, 19: 2677. 10.1093/ndt/gfh359View ArticleGoogle Scholar
  14. Polderman KH: Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality–Part 2: Practical aspects and side effects. Intensive Care Med 2004, 30: 757-769. 10.1007/s00134-003-2151-yView ArticleGoogle Scholar
  15. Polderman KH, Girbes AR, Peerdeman SM, Vandertop WP: Hypothermia. J Neurosurg 2001, 94: 853-858.View ArticleGoogle Scholar
  16. Polderman KH, Peerdeman SM, Girbes AR: Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg 2001, 94: 697-705. 10.3171/jns.2001.94.5.0697View ArticleGoogle Scholar
  17. Shioya N, Ishibe Y, Shibata S, Makabe H, Kan S, Matsumoto N, Takahashi G, Yamada Y, Endo S: Green urine discoloration due to propofol infusion: a case report. Case Rep Emerg Med 2011, 2011: 242514.Google Scholar
  18. Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Hopkins K, Rowland M: Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. Xenobiotica 1988, 18: 429-440. 10.3109/00498258809041679View ArticleGoogle Scholar
  19. Staykov D, Wagner I, Volbers B, Doerfler A, Schwab S, Kollmar R: Mild prolonged hypothermia for large intracerebral hemorrhage. Neurocrit Care 2013, 18: 178-183. 10.1007/s12028-012-9762-5View ArticleGoogle Scholar
  20. Tan CK, Lai CC, Cheng KC: Propofol-related green urine. Kidney Int 2008, 74: 978. 10.1038/ki.2008.139View ArticleGoogle Scholar
  21. Tonseth KA, Tindholdt TT, Hokland BM, Abyholm FE: Green urine after surgical treatment of pressure ulcer. Scand J Plast Reconstr Surg Hand Surg 2007, 41: 39-41. 10.1080/02844310500525406View ArticleGoogle Scholar
  22. Weinberg AD: Hypothermia. Ann Emerg Med 1993, 22: 370-377. 10.1016/S0196-0644(05)80467-6View ArticleGoogle Scholar

Copyright

© Regensburger et al.; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.